For millennia, wartime combatants have sought to hobble the infrastructure of their adversaries by poisoning wells, burning bridges or, more recently, attacking railways, refineries and airports. In ...
The United Nations Office of Counter-Terrorism (UNOCT) Countering Terrorist Travel (‘CT Travel’) Programme organized an interactive training for 41 participants of the competent authorities of ...
Indiana Youth Institute releases KIDS COUNT data book summarizing latest trends in education, health
INDIANAPOLIS — The Indiana Youth Institute has shared its Indiana KIDS COUNT data book, highlighting the needs of Hoosier children. According to a news release, the data revealed that Indiana ranked ...
During its State of Play livestream on Thursday, Sony revealed the first PlayStation Plus Game Catalog addition for February and it's a doozy. Marvel’s Spider-Man 2 (PS5) will finally websling its way ...
Winners & losers: Qualcomm is expanding its Arm-based Windows laptop push with the Snapdragon X2 Plus lineup and is using new benchmark data to claim the chips can outperform current AMD and Intel ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Apple TV All ...
Indiana is positioning itself as a major hub for artificial intelligence with 72 data center facilities. Political leaders see the growth of AI and data centers as a significant economic development ...
Counter-terrorism measures increasingly rely on data-driven tools and advanced technologies to detect and tackle emerging security threats. Data collection, information sharing and strong ...
The deal for Intersect, a data center and energy developer, is set to help Google build out its infrastructure for artificial intelligence. By Eli Tan Reporting from Seattle Google has agreed to buy ...
Please provide your email address to receive an email when new articles are posted on . Azacitidine plus venetoclax significantly improved EFS compared with induction chemotherapy for certain patients ...
In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results